Capital Investment Services of America’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5M Buy
38,977
+347
+0.9% +$195K 2.01% 23
2026
Q1
$21.7M Buy
38,630
+259
+0.7% +$166K 2.27% 18
2025
Q4
$26M Sell
38,371
-1,390
-3% -$947K 2.45% 17
2025
Q3
$25.4M Sell
39,761
-101
-0.3% -$61.3K 2.26% 20
2025
Q2
$21.4M Buy
39,862
+328
+0.8% +$157K 1.96% 26
2025
Q1
$16.6M Buy
39,534
+739
+2% +$321K 1.68% 28
2024
Q4
$16M Buy
38,795
+41
+0.1% +$18K 1.53% 31
2024
Q3
$19.6M Sell
38,754
-2,833
-7% -$1.38M 1.87% 27
2024
Q2
$20.3M Buy
41,587
+508
+1% +$255K 1.96% 25
2024
Q1
$22.2M Sell
41,079
-69
-0.2% -$37.7K 2.14% 25
2023
Q4
$22.8M Sell
41,148
-236
-0.6% -$111K 2.39% 21
2023
Q3
$18.1M Sell
41,384
-32
-0.1% -$16K 2.1% 24
2023
Q2
$20.8M Buy
41,416
+683
+2% +$327K 2.27% 22
2023
Q1
$20.4M Buy
40,733
+89
+0.2% +$42.6K 2.46% 21
2022
Q4
$16.6M Sell
40,644
-427
-1% -$166K 2.2% 21
2022
Q3
$13.4M Buy
41,071
+453
+1% +$166K 1.82% 26
2022
Q2
$14.2M Sell
40,618
-22
-0.1% -$8.97K 1.85% 27
2022
Q1
$26.8M Hold
40,640
2.42% 20
2021
Q4
$26.8M Sell
40,640
-131
-0.3% -$82.2K 2.42% 20
2021
Q3
$25.4M Sell
40,771
-228
-0.6% -$153K 2.41% 15
2021
Q2
$25.9M Buy
40,999
+972
+2% +$537K 2.47% 16
2021
Q1
$19.6M Buy
40,027
+264
+0.7% +$132K 2.02% 28
2020
Q4
$19.9M Buy
39,763
+1,461
+4% +$654K 2.08% 24
2020
Q3
$15.1M Buy
38,302
+1,999
+6% +$739K 1.84% 29
2020
Q2
$12M Buy
36,303
+33,895
+1,408% +$9.81M 1.55% 31
2020
Q1
$583K Buy
2,408
+200
+9% +$52.2K 0.09% 53
2019
Q4
$577K Hold
2,208
0.08% 54
2019
Q3
$600K Hold
2,208
0.09% 52
2019
Q2
$608K Hold
2,208
0.09% 52
2019
Q1
$494K Sell
2,208
-117
-5% -$24.2K 0.08% 50
2018
Q4
$432K Hold
2,325
0.08% 55
2018
Q3
$580K Hold
2,325
0.09% 55
2018
Q2
$507K Hold
2,325
0.08% 54
2018
Q1
$445K Sell
2,325
-1,275
-35% -$235K 0.07% 56
2017
Q4
$563K Sell
3,600
-750
-17% -$118K 0.09% 57
2017
Q3
$676K Sell
4,350
-1,100
-20% -$174K 0.11% 54
2017
Q2
$880K Sell
5,450
-66,878
-92% -$10.9M 0.15% 53
2017
Q1
$11.2M Sell
72,328
-27,941
-28% -$3.85M 1.98% 21
2016
Q4
$11.8M Sell
100,269
-1,650
-2% -$188K 2.22% 18
2016
Q3
$11.5M Sell
101,919
-24,046
-19% -$2.53M 2.19% 20
2016
Q2
$11.7M Sell
125,965
-2,775
-2% -$238K 2.23% 19
2016
Q1
$10.1M Sell
128,740
-1,965
-2% -$141K 1.92% 25
2015
Q4
$9.53M Buy
130,705
+725
+0.6% +$51.7K 1.86% 26
2015
Q3
$9.65M Sell
129,980
-669
-0.5% -$47.9K 2.31% 22
2015
Q2
$8.38M Buy
130,649
+2,785
+2% +$193K 1.91% 33
2015
Q1
$9.88M Sell
127,864
-1,632
-1% -$127K 2.27% 27
2014
Q4
$9.6M Sell
129,496
-150
-0.1% -$10.5K 2.23% 28
2014
Q3
$7.64M Sell
129,646
-150
-0.1% -$9.48K 1.94% 32
2014
Q2
$8.67M Sell
129,796
-500
-0.4% -$31.8K 2.14% 29
2014
Q1
$7.91M Sell
130,296
-1,000
-0.8% -$59.6K 1.99% 32
2013
Q4
$6.98M Sell
131,296
-1,150
-0.9% -$60.5K 1.76% 33
2013
Q3
$6.6M Buy
132,446
+4,650
+4% +$223K 1.76% 34
2013
Q2
$5.73M Buy
+127,796
New +$5.58M 1.65% 36

Other funds holding IDXX

Capital Investment Services of America's IDXX Position: Q2 2026 in Review

Capital Investment Services of America increased its Idexx Laboratories (IDXX) stake by 0.9% in Q2 2026, buying an estimated $195K and bringing the position to 38,977 shares worth $20.5M. The position accounts for 2.01% of the portfolio, ranked #23.

Capital Investment Services of America first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.8M in Q1 2022. 868 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Capital Investment Services of America held 38,977 shares of Idexx Laboratories worth $20.5M as of Q2 2026.
  • Capital Investment Services of America bought 347 Idexx Laboratories shares in Q2 2026, an estimated $195K.
  • Idexx Laboratories made up 2.01% of Capital Investment Services of America's portfolio in Q2 2026, its #23 holding.
  • Capital Investment Services of America first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Capital Investment Services of America's Idexx Laboratories position peaked at $26.8M in Q1 2022.
  • 868 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Capital Investment Services of America's 13F filing for Q2 2026, filed 22 Jul 2026.